Effect of genetic predisposition on the risk of gallbladder cancer in Hungary

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 3, 2008, Pages 391-396

  Kimura, Akira ^a   Tsuchiya, Yasuo ^a   Lang, Istvan ^b   Zoltan, Szentirmay ^b   Nakadaira, Hiroto ^c   Ajioka, Yoichi ^a   Kiyohara, Chikako ^d   Oyama, Mari ^a   Nakamura, Kazutoshi ^a   Yamamoto, Masaharu ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c NIIGATA SEIRYO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

CYP1A1 GSTM1 TP53; Gallbladder cancer; Genetic susceptibility; Single nucleotide polymorphism

Indexed keywords

EID: 67650901964     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Board PG, Coggan M, Chelvanayagam G, et al, (2000). Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem, 275, 24798-806.
2. Caelles C, Helmberg A, Karin M (1994). p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-23.
3. Carriaga MT, Henson DE (1995). Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer, 75, 171-90.
4. Cascorbi I, Brockmöller J, Roots I (1996). A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res, 56, 4965-9.
5. Endoh K, Nakadaira H, Mano H, et al, (1993). Epidemiology of biliary tract cancer in Japan: descriptive studies. Acta Med Biol (Niigata), 41, 113-25.
6. Fan R, Wu MT, Miller D, et al, (2000). The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 1037-42.
7. Garte S, Gaspari L, Alexandrie AK, et al, (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-48.
8. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991). Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem, 110, 407-11.
9. Henson DE, Albores-Saavedra J, Corle D (1992). Carcinoma of the gallbladder. Cancer, 70, 1493-7.
10. Hernádi Z, Szarka K, Sápy T, et al, (2003). The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up. BJOG, 110, 205-9.
11. Kastan MB, Zhan Q, El-Deiry WS, et al, (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-97.
12. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S, (2001). Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis, 14, 1085-9.
13. Kiss I, Sándor J, Pajkos G, et al, (2000). Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res, 20, 519-22.
14. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al, (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64.
15. Lee JM, Lee YC, Yang SY, et al, (2000). Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer, 89, 458-64.
16. Levi F, Lucchini F, Negri E, La Vecchia C, (2003). The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev, 12, 265-7.
17. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO (2001). The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med, 249, 477-93.
18. Muñoz S, Vollrath V, Vallejos MP, et al, (1998). Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile. Pharmacogenetics, 8, 343-51.
19. Nagorney DM, McPherson GAD (1988). Carcinoma of the gallbladder and extrahepatic bile ducts. Semin Oncol, 15, 106-15.
20. Orth K, Berger HG (2000). Gallbladder carcinoma and surgical treatment. Langenbecks Arch Surg, 385, 501-8.
21. Pandey M (2003). Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev, 12, 15-24.
22. Parl FF (2005). Glutathione S-transferase genotypes and cancer risk. Cancer Lett, 221, 123-9.
23. Pemble S, Schroeder KR, Spencer SR, et al, (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J, 300, 271-6.
24. Poncz M, Solowiejczyk D, Harpel B, et al, (1982). Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin, 6, 27-36.
25. Randi G, Franceschi S, La Vecchia C, (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602.
26. Rojas M, Cascorbi I, Alexandrov K, et al, (2000). Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis, 21, 35-41.
27. Schoket B, Papp G, Lévay K, et al, (2001). Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res, 482, 57-69.
28. Strom BL, Soloway RD, Rios-Dalenz JL, et al, (1995). Risk factors for gallbladder cancer. Cancer, 76, 1747-56.
29. Tsuchiya Y, Kiyohara C, Sato T, et al, (2007). Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese. Clin Biochem, 40, 881-6.
30. Wistuba II, Gazdar AF (2004). Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer, 4, 695-706.
31. Yamamoto M, Endoh K, Nakadaira H, et al, (1993). Epidemiology of biliary tract cancer in Japan: analytical studies. Acta Med Biol (Niigata), 41, 127-38,.
32. Zatonskí W, La Vecchia C, Levi F, Negri E, Lucchini F, (1993). Descriptive epidemiology of gall-bladder cancer in Europe. J Cancer Res Clin Oncol, 119, 165-71.
33. Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M (1999). Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet, 354, 218-9.
34. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 821-4.